Survivors Journey+

计划入组 72 人 · 首次发布于 2026 年 1 月 7 日

JOURNEY LVAD: JOURNEY Left Ventricular Assist Device

计划入组 50 人 · 首次发布于 2026 年 1 月 23 日

Gurney Journey: Virtual Reality Distraction

计划入组 58 人 · 首次发布于 2024 年 2 月 28 日

4-azidocytidine analogs (Alios BioPharma/Centers for Disease Control and Prevention)

Recombinant interleukin-4(Southwest Oncology Centers)

LTD-23

Journey Medical

United States

New Journey Healthcare Technology Group Co.,LTD

China

Assuta Medical Centers Ltd.

Israel

Optimi Health's Psilocybin Capsules Approved for Phase 2 Trial in Frontline Healthcare Workers with MDD

Journey Medical's Emrosi Receives FDA Approval for Rosacea Treatment

PromarkerEso Blood Test Shows 94% Accuracy in Esophageal Cancer Detection